Frequency: Bi-monthly
Editor-in-Chief:
Ashutosh P Jadhav MD, PhD
Stroke: Vascular and Interventional Neurology
Stroke: Vascular and Interventional Neurology is a fully Open Access bi-monthly journal that primarily reports clinical, translational, and basic sciences research on interventional, endovascular, medical, and surgical management of stroke and vascular disease of the brain, spinal cord, and head and neck.
In addition, contributions related to other neurological and neurosurgical diseases that may benefit from minimally invasive and innovative approaches from specialties such as Neurology, Radiology, and Neurosurgery from imaging to clinical management are also welcome.
Basic science neurovascular and cardiovascular researchers are welcome to submit their work to the journal.
Imaging, video illustrations, case reports, innovative techniques, angiographic anatomy, clinicopathological correlation, medical devices technical advances, and review papers are also welcome.
As an Open Access journal, S:VIN consists of content that is free on publication to read, download, and share, accelerating the translation of strong science into effective practice.
S:VIN is the official publication of the American Heart Association and the The Society of Vascular and Interventional Neurology.
About SVIN
The Society of Vascular and Interventional Neurology was created to achieve the highest level of care for patients through increased collaboration in scientific research and by educating young professionals and training young investigators. The Society also aims to provide opportunities to connect leaders in the field and provide a common ground for dialogue and the creation of practice and safety standards.
About American Heart Association
From humble beginnings, the American Heart Association (AHA) has grown into the United States' oldest and largest voluntary organization dedicated to fighting heart disease and stroke. A shared focus on cardiovascular health unites more than 35 million volunteers and supporters as well as over 2,900 employees.
Heart disease is the No. 1 killer worldwide, and stroke ranks second globally. Even when those conditions don’t result in death, they cause disability and diminish quality of life. The AHA wants to see a world free of cardiovascular diseases and stroke.
The size and scope of AHA creates real impact. The assocation has invested more than $5 billion in research, making them the largest not-for-profit funding source for cardiovascular and cerebrovascular disease research next to the federal government.
The AHA's mission is to be a relentless force for a world of longer, healthier lives.
